登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）控股股东、实际控制人刘召贵先生正在筹划公司控 制权变更相关事宜，该事项可能导致公司控股股东及实际控制人发生变更。为保证公平信息披露，避免 公司股价异常波动，维护广大投资者利益，经公司向深圳证券交易所申请，公司股票（股票简称：ST 天瑞，股票代码：300165）自2025年12月1日（星期一）开市起停牌，预计停牌时间不超过2个交易日。 江苏天瑞仪器股份有限公司董事会 二○二五年十二月一日 公司今日收到控股股东、实际控制人、董事长刘召贵先生出具的《关于筹划公司控制权变更事项的告知 函》，获悉刘召贵先生正在筹划公司控制权变更相关事宜，目前各方尚未签署相关协议，拟就具体交易 方案、协议等相关事项进行论证和磋商，具体情况以各方签订的相关协议为准。 鉴于上述事项尚存在重大不确定性，为保证公平信息披露，避免造成公司股价异常波动，维护广大投资 者利益，根据《深圳证券交易所上市公司自律监管指引第6号一一停复牌》相关规定，经 ...

Major Events - Enjie Co., Ltd. is planning to acquire 100% equity of Zhongke Hualian and will suspend trading starting December 1, 2025 due to uncertainties surrounding the transaction [4] - ST Tianrui's controlling shareholder is planning a change in company control, leading to a trading suspension starting December 1, 2025, expected to last no more than two trading days [5] - Jiarong Technology intends to raise no more than 1 billion yuan through a private placement and acquire 100% of Hangzhou Lanran [6][7] - Baili Tianheng's wholly-owned subsidiary received a milestone payment of 250 million USD from BMS related to a collaboration agreement [8] - Jiangxi Copper is planning to acquire shares of the overseas listed company SolGold Plc, with a non-binding cash offer of 26 pence per share, currently in the informal offer stage [9] - China Shenhua's subsidiary successfully completed a 168-hour trial run of its power generation unit, marking a significant milestone in its expansion project [10] - ST Dongyi faces the risk of bankruptcy due to unsuccessful restructuring efforts, which could lead to stock delisting [11] - Huayang Co., Ltd. has launched a high-performance carbon fiber project with an annual production capacity of 200 tons, applicable in various high-tech fields [12] - Dameng Data's general manager has had his detention lifted by the local authorities [13] Shareholding Changes - Zhongwei Company plans to reduce its stake by no more than 1% through block trading, equating to approximately 6.26 million shares [14] - Yulide's directors plan to collectively reduce their holdings by no more than 0.0313%, totaling up to 35,000 shares [15] - Shengnuo Bio's vice president and a board member plan to reduce their holdings by no more than 0.024%, totaling up to 37,600 shares [16] Major Contracts - Aoride plans to sign a comprehensive technical service agreement with Company X, with a total contract value of approximately 635 million yuan [17]

Core Viewpoint - ST Tianrui is planning a change in company control after four consecutive years of losses, with the actual controller Liu Zhaogui initiating discussions on this matter [1]. Group 1: Company Control Change - On November 30, ST Tianrui announced that it received a notice from its controlling shareholder and chairman Liu Zhaogui regarding the planning of a change in company control [1]. - Currently, no agreements have been signed, and discussions on specific transaction plans and agreements are ongoing [1]. - Due to the uncertainty surrounding this matter, ST Tianrui has applied for a trading suspension starting December 1, 2025, for up to two trading days [1]. Group 2: Financial Performance - ST Tianrui has experienced continuous losses from 2021 to 2024, with revenue declining from 2022 to 2024 [2]. - The company's main business includes analysis and detection instruments, as well as environmental governance [2]. Group 3: Stock Information - As of November 28, ST Tianrui's stock closed at 4.64 yuan per share, with a market capitalization of 2.299 billion yuan [3].

Group 1 - The core point of the article is that ST Tianrui's actual controller is planning to change the company's control rights after four consecutive years of losses [2] - On November 30, ST Tianrui announced that it received a notice from its controlling shareholder and chairman, Liu Zhaogui, regarding the planning of a change in control [2] - The company has applied for a trading suspension starting December 1, 2025, due to the uncertainty surrounding the control change [2] Group 2 - ST Tianrui has experienced continuous losses from 2021 to 2024, with declining revenue from 2022 to 2024 [3] - As of November 28, ST Tianrui's stock price was reported at 4.64 yuan per share, with a market capitalization of 2.299 billion yuan [5] - In May 2023, Liu Zhaogui signed a share transfer agreement with Guangzhou Lidu Virtual Reality Technology Partnership, which could lead to a new actual controller if completed [2]

Core Viewpoint - ST Tianrui is planning a change in company control due to continuous losses over the past four years, indicating a potential "shell sale" [2] Group 1: Control Change Announcement - On November 30, ST Tianrui announced that its controlling shareholder and chairman, Liu Zhaogui, is planning a change in company control, with no agreements signed yet [2] - The company has applied for a trading suspension starting December 1, 2025, for up to two trading days due to the uncertainty surrounding the control change [4] Group 2: Previous Control Change Attempts - In May 2023, Liu Zhaogui signed a share transfer agreement with Guangzhou Lidu Virtual Reality Technology Partnership, aiming for a control change where Li Gang would become the actual controller [4] - However, in late May 2024, ST Tianrui announced the termination of the control change due to changes in the financing environment [5] Group 3: Financial Performance - ST Tianrui's main business includes analytical testing instruments and environmental governance, but the company has reported continuous losses from 2021 to 2024, with declining revenue from 2022 to 2024 [6] - As of November 28, the stock price was 4.64 yuan per share, with a market capitalization of 2.299 billion yuan [9]

Company Focus - Enjie Co., Ltd. plans to acquire 100% equity of Zhongke Hualian, leading to a stock suspension [2] - Canadian Solar Inc. and its controlling shareholder plan to establish a joint venture to adjust their U.S. market operations [3] - Jiarong Technology intends to acquire 100% of Hangzhou Lanan, with stock resuming trading [3] Equity Changes - ST Tianrui's controlling shareholder is planning a change in control, resulting in stock suspension [4] Shareholding Changes & Buybacks - Shanghai Chuangtou intends to reduce its stake in Zhongwei Company by no more than 1% [5] Operations & Performance - China Shenhua's subsidiary successfully completed a 168-hour trial run of its power generation unit, transitioning to commercial operation [6] - Baillie Tianheng received a milestone payment of $250 million from Bristol-Myers Squibb for the iza-bren project [7] - Jiangxi Copper is in the informal offer stage to acquire shares of SolGold Plc [8] - Aorede plans to sign a 635 million yuan computing power procurement agreement [9] - Maiwei Bio's clinical research for 9MW1911 shows significant reductions in acute exacerbation rates for COPD patients [10] - Huayang Co. has launched a high-performance carbon fiber project with an annual production capacity of 200 tons [10] Financing & Capital Increase - Ganfeng Lithium plans to issue $100 million in exchangeable notes to the China-Africa Development Fund [11] Stock Price Fluctuations - Tongyu Communications confirmed normal operations amid stock price fluctuations [12] - Rongji Software reported normal operations despite stock price declines [13] Other - Xianglou New Materials' application for a specific stock issuance has been accepted by the Shenzhen Stock Exchange [15] - JinkoSolar received a prepayment of 220 million yuan for a fire incident at its battery workshop [15] - Dameng Data's general manager has had his detention lifted [15] - Dongpeng Beverage has received approval from the CSRC for its overseas listing [16]

Core Viewpoint - ST Tianrui is undergoing a potential change in control, as announced by its controlling shareholder and chairman Liu Zhaogui, with no agreements signed yet [1] Company Overview - ST Tianrui is a high-tech enterprise with independent intellectual property, owning nine wholly-owned subsidiaries and five controlling subsidiaries, specializing in the research, production, and sales of analytical testing instruments and software [2] Financial Performance - For the first three quarters of 2025, ST Tianrui reported a revenue of 435 million yuan, a year-on-year decrease of 26.15%, and a net profit attributable to shareholders of a loss of 1.22 million yuan [2] Stock Information - As of November 28, ST Tianrui's stock price was 4.64 yuan per share, with a total market capitalization of approximately 2.3 billion yuan [3]

Core Viewpoint - ST Tianrui (300165) is undergoing a potential change in control, as announced by its chairman Liu Zhaogui, with no agreements signed yet [2][4]. Company Overview - ST Tianrui is a high-tech enterprise with independent intellectual property rights, operating nine wholly-owned subsidiaries and five controlling subsidiaries, focusing on the research, production, and sales of analytical testing instruments [4]. Financial Performance - For the first three quarters of 2025, ST Tianrui reported a revenue of 435 million yuan, a year-on-year decrease of 26.15%, and a net loss attributable to shareholders of 1.22 million yuan [5][6]. - The company's revenue for the latest reporting period was approximately 140 million yuan, reflecting a decline of 33.03% compared to the same period last year [6]. - The net profit attributable to shareholders for the same period was approximately 8.37 million yuan, an increase of 3.95% year-on-year [6]. - The basic earnings per share for the latest reporting period was 0.0169 yuan, up 4.22% from the previous year [6].

Core Viewpoint - Several companies are undergoing significant corporate actions, including acquisitions, capital raising, and operational milestones, which may present investment opportunities and market implications. Group 1: Corporate Actions - Enjie Co., Ltd. is planning to acquire 100% equity of Zhongke Hualian and will suspend trading starting December 1, 2025 due to uncertainties surrounding the transaction [3] - ST Tianrui's controlling shareholder is planning a change in company control, leading to a trading suspension from December 1, 2025, expected to last no more than two trading days [4] - Jiarong Technology intends to raise up to 1 billion yuan through a private placement and acquire 100% of Hangzhou Lanran, with the transaction making the latter a wholly-owned subsidiary [5] - Jiangxi Copper is in the process of making non-binding cash offers to acquire shares of SolGold Plc at 26 pence per share, currently holding 12.19% of the company [7] Group 2: Financial Milestones - Baillie Gifford's subsidiary SystImmune received a milestone payment of $250 million from Bristol-Myers Squibb related to a collaboration agreement, with potential future payments totaling up to $7.1 billion [6] Group 3: Operational Developments - China Shenhua's subsidiary successfully completed a 168-hour trial run of its 3rd unit at the Beihai Phase II project, which is a key energy development project in Guangxi [8] - Huayang Co., Ltd. has launched a 200-ton annual production project for high-performance carbon fiber, which is expected to serve various high-tech industries [11] Group 4: Shareholder Actions - Zhongwei Company’s major shareholder plans to reduce its stake by up to 1% through block trading [14] - Yulide's directors plan to collectively reduce their holdings by no more than 0.0313% of the company's total shares [15] - Saint Noble Bio's executives plan to reduce their holdings by no more than 0.024% of the company's total shares [16] Group 5: Contracts and Agreements - Aoride plans to sign a comprehensive technical service agreement with Company X, with a total contract value of approximately 635 million yuan [18]

新京报贝壳财经讯11月30日，ST天瑞（300165）公告称，公司控股股东、实际控制人刘召贵正在筹划 公司控制权变更相关事宜，可能导致公司控股股东及实际控制人发生变更。为保证公平信息披露，避免 公司股价异常波动，公司股票自2025年12月1日开市起停牌，预计停牌时间不超过2个交易日。本次交易 事项能否最终实施完成及实施结果尚存在不确定性。 ...